Wrinkle
Conditions
Keywords
skin aging, fine lines, crow's feet, dark circles
Brief summary
Saie Beauty has developed 'Hydrabeam Sheer Brightening Under Eye Concealer' that is specifically designed for improving under-eye skin health. The concealer is aimed at improving under-eye skin features including hydration, firmness/elasticity, smoothness, and brightness. At the same time, it is aimed at reducing imperfections such as dark circles, skin redness, fine lines, wrinkles, and crow's feet. The aim is to understand and assess the efficacy of treatment from the participants' perspective and to see if the participants reported changes in skin features, dark circles, brightness, fine lines, wrinkles, crow's feet, and other skin imperfections.
Interventions
DIETARY_SUPPLEMENTSaie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer
Eye Concealer
Sponsors
Saie Beauty
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Masking description
Open label
Intervention model description
This is an open-label single-group, non-randomized, non-controlled interventional treatment study.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Female between 18 and 45 years old * Must be in good general health * Want to improve under-eye skin health by improving skin hydration, firmness/elasticity, smoothness, and brightness * May have dark circles, fine lines, wrinkles, and crow's feet * Must be willing to comply with the study protocol * Must be willing to add the concealer to their daily routine for the duration of the study * Must maintain a basic skincare routine, e.g., must use moisturizer and sunscreen daily * Able to communicate in English * Must provide a written Informed Consent Form (ICF) * Willing to share feedback via the given online portal
Exclusion criteria
* Unwilling to follow the routine of the study * Unwilling to provide informed consent * Currently participating in another research study * Severe chronic conditions including ontological and psychiatric conditions * Use of prescription medication relevant for the skin * Have any known allergies to the ingredients of the test product * Known to have any severe allergic reactions in the past * Undergoing any cosmetic procedures such as laser treatments, Botox, or chemical peels for the duration of the study. * Have diagnosed or self-identified sensitive skin * Have any learning and/or cognitive difficulties that prevent them from reading and understanding questionnaires and surveys (e.g. dementia) * Currently pregnant or breastfeeding, or want to become pregnant for the duration of the study * Use of prescription drugs (topical or oral) that are targeted at any sort of skin condition (for example retinoids)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Skin aging [Time frame: Baseline to 4 weeks] | 4 weeks | Patient reported outcome measures (Scale 0-5 with higher scores representing a better outcome) to assess the reduction of early signs of aging such as fine lines, dark spots, and brighter skin |
Countries
United States
Outcome results
None listed